US Patent Issued to MERUS on Sept. 1 for "Methods of treating cancer using binding molecules that bind CD137 and PD-L1" (Dutch Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,095, issued on Sept. 1, was assigned to MERUS N.V. (Utrecht, Netherlands).

"Methods of treating cancer using binding molecules that bind CD137 and PD-L1" was invented by Cecilia Anna Wilhelmina Geuijen (Utrecht, Netherlands), Mark Throsby (Utrecht, Netherlands), Cornelis Adriaan De Kruif (Utrecht, Netherlands), Rinse Klooster (Utrecht, Netherlands), Paulus Johannes Tacken (Utrecht, Netherlands) and Ton Logtenberg (Utrecht, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides means and methods of stimulating activity of a member of the TNF receptor superfamily on a cell. The invention also provides binding molecules such ...